The restricted mean survival time as a replacement for the hazard ratio and the number needed to treat in long‐term studies

AIMS: We applied the restricted mean survival time (RMST) to analyse the survival data reported in the PARADIGM‐HT trial in which sacubitril + valsartan was studied in comparison with enalapril in patients with heart failure. The estimates of this parameter were compared with the published values of...

Descripción completa

Detalles Bibliográficos
Autores principales: Messori, Andrea, Bartoli, Laura, Trippoli, Sabrina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120383/
https://www.ncbi.nlm.nih.gov/pubmed/33733623
http://dx.doi.org/10.1002/ehf2.13306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120383/
https://www.ncbi.nlm.nih.gov/pubmed/33733623
http://dx.doi.org/10.1002/ehf2.13306

Ejemplares similares